We’re innovative thought leaders and determined advocates who partner with visionary organizations to change health care.
We’re innovative thought leaders and determined advocates who partner with visionary organizations to change health care.
We’re innovative thought leaders and determined advocates who partner with visionary organizations to change health care.
In addition to being mission-driven, we contribute 5% of profits to charities that deliver health care to those in need.
In addition to being mission-driven, we contribute 5% of profits to charities that deliver health care to those in need.
In addition to being mission-driven, we contribute 5% of profits to charities that deliver health care to those in need.
We're working to improve health for all, including enhancing quality, reducing costs, and expanding access to care.
We're working to improve health for all, including enhancing quality, reducing costs, and expanding access to care.
We're working to improve health for all, including enhancing quality, reducing costs, and expanding access to care.
The Wynne Health Group is the only mission-driven, public interest government relations firm focused on health and well-being.
OUR SERVICES
If you believe that every American deserves to be healthy and well, contact the Wynne Health Group to learn how our expertise can help you achieve your goals.
Policy Hub, managed by Wynne Health Group, is the only comprehensive database of Federal health policy developments, cataloged by over 200 healthcare topics and programs. Regulations, reimbursement, grants, ACA implementation, hearing summaries, CRS Reports, pending legislation – you get it all here, with comprehensive, expert analysis.
Draft Guidance Issued on Recommendations for Evaluating Donor Eligibility Using Individual Risk-Based Questions to Reduce the Risk of HIV Transmission by Blood and Blood Products
The Food and Drug Administration (FDA) issued draft guidance on recommendations for evaluating donor eligibility using individual risk-based questions to reduce the risk of Human Immunodeficiency Virus (HIV) transmission by blood and blood products. The draft guidance is intended to provide blood establishments that collect blood or blood components, including Source Plasma, the following for individuals with increased risk of… (Slifer, January 27, 2023) #Food and Drug Administration, #Health Equity, #Prescription Drugs
New Requirements for Unwinding from COVID-19 PHE for State Medicaid and CHIP Programs
The Centers for Medicare and Medicaid Services (CMS) issued guidance outlining new requirements for state Medicaid and CHIP programs in Consolidated Appropriations Act of 2023 (CAA, P.L. 117-328) regarding the unwinding of continuous coverage requirements and conditions for receipt of the temporary FMAP increase. CMS also discusses reporting requirements, enforcement activities, and implications of CAA for certain COVID-19 Public Health… (Llamas, January 27, 2023) #Coverage Decisions, #COVID-19